PRODUCTS

..............................................................

PRE-QUALIFIED HUMAN CELLS

PURE CARDIOMYOCYTES

.

LABORATORY SERVICES

..............................................................

CONTRACT ASSAY SERVICES

CONTRACT RESEARCH

ASSAY DESIGN & DEVELOPMENT

OPTIONAL ON-SITE SERVICES

.

EDUCATIONAL SERVICES

..............................................................

SUMMARY OF EDUCATIONAL SERVICES

.

CONSULTING

..............................................................

SUMMARY OF CONSULTING SERVICES

..............................................................

 

What's New

 

ReachBio is now the exclusive North American distributor for Axiogenesis AG.  Initial products consist of Cor.AT® pure cardiomyocytes for drug development, cardiotoxicity, hypertrophy and electrophysiology applications.

 

:: more info

 

..............................

 

CONFERENCES

 

Society of Toxicology (SOT), Booth and Exhibitor Hosted Seminar

 

Molecular Medicine Tri Conference Booth Exhibit

 

 

 

 

Home > Contract Assay > In Vivo Assays > In Vivo Effects of Compound Administration

 

In Vivo Effects of Compound Administration

 

The ultimate biological effect of certain agents (e.g. chemokines, cytokines, mimetics) may be direct or indirect. In vitro assays are powerful tools to evaluate direct effects but may not be adequate to reveal or evaluate indirect effects. In these cases, we recommend in vivo administration of the test compounds with subsequent assessment of various parameters such as cell counts, CFC frequency, engraftment potential, etc.

 

ReachBio can assess the following after in vivo administration of test compounds:

 

  • Blood cell counts (white blood cells, red blood cells and platelets)

  • Colony Forming Cell (CFC) content per ml of blood

  • Kinetics of drug activity

  • In vivo effects of drug dose

  • Comparative activity of various factors

 

ReachBio's comprehensive service for determining the in vivo effects of compound administration includes:

  • Initial consultation with Study Director*

  • Assay selection and design

  • Study execution

  • Data interpretation

  • Full written report

  • Follow-up consultation

  • Full confidentiality

 

Please contact us to discuss your needs.

 

* ReachBio Study Directors are highly knowledgeable and have many years of experience in the scientific and practical aspects of assessing the in vivo effects of compound administration.

 

 

 © ReachBio LLC    All Rights Reserved

 

1 206 420 0300  |